Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.04
NYSE:COO's Cash to Debt is ranked lower than
96% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. NYSE:COO: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:COO' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: 1.92
Current: 0.04
0
1.92
Equity to Asset 0.60
NYSE:COO's Equity to Asset is ranked higher than
53% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. NYSE:COO: 0.60 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:COO' s Equity to Asset Range Over the Past 10 Years
Min: 0.15  Med: 0.59 Max: 0.8
Current: 0.6
0.15
0.8
Interest Coverage 11.39
NYSE:COO's Interest Coverage is ranked lower than
65% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.77 vs. NYSE:COO: 11.39 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:COO' s Interest Coverage Range Over the Past 10 Years
Min: 1.07  Med: 9.13 Max: 38.48
Current: 11.39
1.07
38.48
F-Score: 5
Z-Score: 3.93
M-Score: -2.57
WACC vs ROIC
6.10%
6.91%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 15.35
NYSE:COO's Operating margin (%) is ranked higher than
81% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.89 vs. NYSE:COO: 15.35 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:COO' s Operating margin (%) Range Over the Past 10 Years
Min: 4.82  Med: 15.13 Max: 19.61
Current: 15.35
4.82
19.61
Net-margin (%) 13.14
NYSE:COO's Net-margin (%) is ranked higher than
82% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.04 vs. NYSE:COO: 13.14 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:COO' s Net-margin (%) Range Over the Past 10 Years
Min: -1.18  Med: 10.54 Max: 18.65
Current: 13.14
-1.18
18.65
ROE (%) 9.32
NYSE:COO's ROE (%) is ranked higher than
64% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. NYSE:COO: 9.32 )
Ranked among companies with meaningful ROE (%) only.
NYSE:COO' s ROE (%) Range Over the Past 10 Years
Min: -0.79  Med: 7.4 Max: 12.88
Current: 9.32
-0.79
12.88
ROA (%) 5.56
NYSE:COO's ROA (%) is ranked higher than
67% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.61 vs. NYSE:COO: 5.56 )
Ranked among companies with meaningful ROA (%) only.
NYSE:COO' s ROA (%) Range Over the Past 10 Years
Min: -0.45  Med: 4.5 Max: 9.74
Current: 5.56
-0.45
9.74
ROC (Joel Greenblatt) (%) 19.34
NYSE:COO's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.16 vs. NYSE:COO: 19.34 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:COO' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 5.39  Med: 17.35 Max: 29.5
Current: 19.34
5.39
29.5
Revenue Growth (3Y)(%) 7.50
NYSE:COO's Revenue Growth (3Y)(%) is ranked higher than
62% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. NYSE:COO: 7.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:COO' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.4  Med: 13.4 Max: 27.9
Current: 7.5
5.4
27.9
EBITDA Growth (3Y)(%) 2.20
NYSE:COO's EBITDA Growth (3Y)(%) is ranked lower than
62% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. NYSE:COO: 2.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:COO' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -8.6  Med: 16.1 Max: 62.8
Current: 2.2
-8.6
62.8
EPS Growth (3Y)(%) -6.40
NYSE:COO's EPS Growth (3Y)(%) is ranked lower than
71% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. NYSE:COO: -6.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:COO' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -18.7  Med: 14.9 Max: 36.4
Current: -6.4
-18.7
36.4
» NYSE:COO's 10-Y Financials

Financials (Next Earnings Date: 2016-12-08)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

COO Guru Trades in Q4 2015

George Soros 6,500 sh (New)
Jim Simons 132,198 sh (+15.96%)
David Carlson 210,000 sh (+10.53%)
Ken Fisher 93,854 sh (+1.37%)
Mario Gabelli 28,500 sh (unchged)
Samuel Isaly 205,000 sh (unchged)
Ray Dalio Sold Out
Pioneer Investments Sold Out
Paul Tudor Jones Sold Out
Ron Baron 243,262 sh (-27.20%)
» More
Q1 2016

COO Guru Trades in Q1 2016

Manning & Napier Advisors, Inc 600,385 sh (New)
Steven Cohen 46,500 sh (New)
Paul Tudor Jones 1,662 sh (New)
Ron Baron 270,063 sh (+11.02%)
Mario Gabelli 28,500 sh (unchged)
David Carlson 210,000 sh (unchged)
Samuel Isaly 205,000 sh (unchged)
Jim Simons Sold Out
George Soros Sold Out
Ken Fisher 93,114 sh (-0.79%)
» More
Q2 2016

COO Guru Trades in Q2 2016

Steven Cohen 268,400 sh (+477.20%)
Paul Tudor Jones 3,355 sh (+101.87%)
Ken Fisher 106,914 sh (+14.82%)
Ron Baron 270,131 sh (+0.03%)
David Carlson 210,000 sh (unchged)
Mario Gabelli 28,500 sh (unchged)
Samuel Isaly 205,000 sh (unchged)
Manning & Napier Advisors, Inc 562,995 sh (-6.23%)
» More
Q3 2016

COO Guru Trades in Q3 2016

Joel Greenblatt 14,334 sh (New)
Pioneer Investments 188,076 sh (New)
Paul Tudor Jones 4,816 sh (+43.55%)
Ken Fisher 114,974 sh (+7.54%)
Steven Cohen 270,800 sh (+0.89%)
Mario Gabelli 28,500 sh (unchged)
Samuel Isaly 205,000 sh (unchged)
Ron Baron 264,731 sh (-2.00%)
David Carlson 190,000 sh (-9.52%)
Manning & Napier Advisors, Inc 354,911 sh (-36.96%)
» More
» Details

Insider Trades

Latest Guru Trades with COO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:OTCPK:RSMDF, NYSE:WST, NAS:HOLX, OTCPK:SAUHY, NYSE:STE, NYSE:MTD, NYSE:WAT, OTCPK:OCPNY, OTCPK:GNGBY, NYSE:HRC, NYSE:CMN, OTCPK:TRUMF, NAS:XRAY, OTCPK:ANSLY, NAS:ICUI, NAS:PODD, NYSE:HAE, NYSE:HYH, NAS:NXTM, OTCPK:TOPCF » details
Traded in other countries:CP6.Germany, COO.Mexico,
The Cooper Companies Inc is a medical device company. Through its subsidiaries, it manufactures products for contact lens wearers and supplies women's health clinicians with products and treatment options to improve the delivery of healthcare to women.

The Cooper Companies Inc is a Delaware corporation, which was organized on March 4, 1980. It is a medical device company. Through its subsidiaries, it manufactures products for contact lens wearers and supplies women's health clinicians with products and treatment options to improve the delivery of healthcare to women. It develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring materials and optics. It products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness; with a broad collection of spherical, toric and multifocal contact lenses. The Company's customers are healthcare professionals and institutions providing care to and for women. Its products support the point of healthcare delivery in the hospital, clinician's office and fertility clinics. The Company's manufacturing and distribution facilities are located in Trumbull, Connecticut, Malov, Denmark, Pasadena, California, Stafford, Texas, and Berlin, Germany. The Company's raw materials consist of various chemicals and packaging materials and are generally available from more than one source. It markets its products in the United States through field sales representatives, who call on optometrists, ophthalmologists, opticians, optical chains and distributors. The Company's products are medical devices subject to extensive regulation by the United States Food and Drug Administration (FDA) in the United States and other regulatory bodies abroad.

Guru Investment Theses on The Cooper Companies Inc

Baron Funds Comments on The Cooper Companies - Jan 26, 2016

Shares of The Cooper Companies, Inc. (NYSE:COO), a global contact lens manufacturer, fell after its earnings fell short of Wall Street expectations. Results were negatively impacted by missteps in integrating its recent acquisition of Sauflon Pharmaceuticals Ltd., a British contact lens company, as well as fallout from new competitive lenses. Management projected moderating market share gains and lowered the company’s targeted five-year growth rate. Although disappointed, we remain cautiously optimistic, given Cooper’s reduced valuation and our belief that its revised earnings targets are achievable. Furthermore, we believe that shifts in the contact lens market toward greater adoption of silicon hydrogel lenses and daily modalities will play to Cooper’s strengths.



From Baron Funds' Baron Asset Fund commentary for fourth quarter 2015.



Check out Ron Baron latest stock trades

Top Ranked Articles about The Cooper Companies Inc

Baron Funds Comments on The Cooper Companies Guru stock highlight
Shares of The Cooper Companies, Inc. (NYSE:COO), a global contact lens manufacturer, fell after its earnings fell short of Wall Street expectations. Results were negatively impacted by missteps in integrating its recent acquisition of Sauflon Pharmaceuticals Ltd., a British contact lens company, as well as fallout from new competitive lenses. Management projected moderating market share gains and lowered the company’s targeted five-year growth rate. Although disappointed, we remain cautiously optimistic, given Cooper’s reduced valuation and our belief that its revised earnings targets are achievable. Furthermore, we believe that shifts in the contact lens market toward greater adoption of silicon hydrogel lenses and daily modalities will play to Cooper’s strengths. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 32.66
COO's P/E(ttm) is ranked lower than
61% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.20 vs. COO: 32.66 )
Ranked among companies with meaningful P/E(ttm) only.
COO' s P/E(ttm) Range Over the Past 10 Years
Min: 8.06  Med: 22.5 Max: 1011.75
Current: 32.66
8.06
1011.75
Forward P/E 16.61
COO's Forward P/E is ranked higher than
80% of the 35 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.22 vs. COO: 16.61 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 32.66
COO's PE(NRI) is ranked lower than
62% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.71 vs. COO: 32.66 )
Ranked among companies with meaningful PE(NRI) only.
COO' s PE(NRI) Range Over the Past 10 Years
Min: 8.06  Med: 22.5 Max: 1011.75
Current: 32.66
8.06
1011.75
Price/Owner Earnings (ttm) 35.38
COO's Price/Owner Earnings (ttm) is ranked lower than
64% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.97 vs. COO: 35.38 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
COO' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 13.85  Med: 24.05 Max: 195
Current: 35.38
13.85
195
P/B 2.97
COO's P/B is ranked higher than
54% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. COO: 2.97 )
Ranked among companies with meaningful P/B only.
COO' s P/B Range Over the Past 10 Years
Min: 0.37  Med: 1.82 Max: 3.62
Current: 2.97
0.37
3.62
P/S 4.29
COO's P/S is ranked lower than
63% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. COO: 4.29 )
Ranked among companies with meaningful P/S only.
COO' s P/S Range Over the Past 10 Years
Min: 0.51  Med: 2.85 Max: 5.22
Current: 4.29
0.51
5.22
PFCF 33.35
COO's PFCF is ranked lower than
64% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.13 vs. COO: 33.35 )
Ranked among companies with meaningful PFCF only.
COO' s PFCF Range Over the Past 10 Years
Min: 7.33  Med: 26.52 Max: 353.03
Current: 33.35
7.33
353.03
POCF 19.44
COO's POCF is ranked lower than
58% of the 99 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.52 vs. COO: 19.44 )
Ranked among companies with meaningful POCF only.
COO' s POCF Range Over the Past 10 Years
Min: 5.63  Med: 14.64 Max: 21.95
Current: 19.44
5.63
21.95
EV-to-EBIT 32.95
COO's EV-to-EBIT is ranked lower than
72% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.32 vs. COO: 32.95 )
Ranked among companies with meaningful EV-to-EBIT only.
COO' s EV-to-EBIT Range Over the Past 10 Years
Min: 11.4  Med: 21.2 Max: 72
Current: 32.95
11.4
72
EV-to-EBITDA 19.43
COO's EV-to-EBITDA is ranked lower than
60% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.51 vs. COO: 19.43 )
Ranked among companies with meaningful EV-to-EBITDA only.
COO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.9  Med: 14.9 Max: 24.4
Current: 19.43
6.9
24.4
PEG 3.08
COO's PEG is ranked lower than
59% of the 61 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. COO: 3.08 )
Ranked among companies with meaningful PEG only.
COO' s PEG Range Over the Past 10 Years
Min: 0.78  Med: 2.08 Max: 22.9
Current: 3.08
0.78
22.9
Shiller P/E 45.62
COO's Shiller P/E is ranked lower than
54% of the 46 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.02 vs. COO: 45.62 )
Ranked among companies with meaningful Shiller P/E only.
COO' s Shiller P/E Range Over the Past 10 Years
Min: 7.2  Med: 35.24 Max: 59.5
Current: 45.62
7.2
59.5
Current Ratio 2.90
COO's Current Ratio is ranked higher than
62% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.44 vs. COO: 2.90 )
Ranked among companies with meaningful Current Ratio only.
COO' s Current Ratio Range Over the Past 10 Years
Min: 0.98  Med: 2.18 Max: 3.46
Current: 2.9
0.98
3.46
Quick Ratio 1.56
COO's Quick Ratio is ranked lower than
53% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. COO: 1.56 )
Ranked among companies with meaningful Quick Ratio only.
COO' s Quick Ratio Range Over the Past 10 Years
Min: 0.69  Med: 1.23 Max: 2.95
Current: 1.56
0.69
2.95
Days Inventory 200.17
COO's Days Inventory is ranked lower than
78% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 122.94 vs. COO: 200.17 )
Ranked among companies with meaningful Days Inventory only.
COO' s Days Inventory Range Over the Past 10 Years
Min: 167.05  Med: 207.61 Max: 231.4
Current: 200.17
167.05
231.4
Days Sales Outstanding 58.93
COO's Days Sales Outstanding is ranked higher than
57% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.71 vs. COO: 58.93 )
Ranked among companies with meaningful Days Sales Outstanding only.
COO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.77  Med: 58.81 Max: 63.16
Current: 58.93
52.77
63.16
Days Payable 41.39
COO's Days Payable is ranked lower than
58% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.76 vs. COO: 41.39 )
Ranked among companies with meaningful Days Payable only.
COO' s Days Payable Range Over the Past 10 Years
Min: 27.82  Med: 55.91 Max: 72.43
Current: 41.39
27.82
72.43

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.04
COO's Dividend Yield is ranked lower than
100% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. COO: 0.04 )
Ranked among companies with meaningful Dividend Yield only.
COO' s Dividend Yield Range Over the Past 10 Years
Min: 0.03  Med: 0.09 Max: 0.52
Current: 0.04
0.03
0.52
Dividend Payout 0.01
COO's Dividend Payout is ranked higher than
99% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. COO: 0.01 )
Ranked among companies with meaningful Dividend Payout only.
COO' s Dividend Payout Range Over the Past 10 Years
Min: 0.01  Med: 0.04 Max: 0.25
Current: 0.01
0.01
0.25
Forward Dividend Yield 0.04
COO's Forward Dividend Yield is ranked lower than
100% of the 141 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. COO: 0.04 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.04
COO's Yield on cost (5-Year) is ranked lower than
99% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. COO: 0.04 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
COO' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.03  Med: 0.09 Max: 0.52
Current: 0.04
0.03
0.52
3-Year Average Share Buyback Ratio 0.10
COO's 3-Year Average Share Buyback Ratio is ranked higher than
83% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. COO: 0.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
COO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -12.9  Med: -1.6 Max: 1.2
Current: 0.1
-12.9
1.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 165.86
COO's Price/Tangible Book is ranked lower than
99% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.34 vs. COO: 165.86 )
Ranked among companies with meaningful Price/Tangible Book only.
COO' s Price/Tangible Book Range Over the Past 10 Years
Min: 3.27  Med: 8.8 Max: 1768
Current: 165.86
3.27
1768
Price/Projected FCF 1.70
COO's Price/Projected FCF is ranked higher than
58% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. COO: 1.70 )
Ranked among companies with meaningful Price/Projected FCF only.
COO' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.57  Med: 1.62 Max: 5.86
Current: 1.7
0.57
5.86
Price/DCF (Earnings Based) 3.00
COO's Price/DCF (Earnings Based) is ranked lower than
75% of the 16 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.98 vs. COO: 3.00 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.49
COO's Price/Median PS Value is ranked lower than
73% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. COO: 1.49 )
Ranked among companies with meaningful Price/Median PS Value only.
COO' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.26  Med: 1.03 Max: 2.59
Current: 1.49
0.26
2.59
Price/Peter Lynch Fair Value 4.89
COO's Price/Peter Lynch Fair Value is ranked lower than
89% of the 37 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.63 vs. COO: 4.89 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
COO' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.6  Med: 1.37 Max: 70
Current: 4.89
0.6
70
Price/Graham Number 15.42
COO's Price/Graham Number is ranked lower than
98% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.45 vs. COO: 15.42 )
Ranked among companies with meaningful Price/Graham Number only.
COO' s Price/Graham Number Range Over the Past 10 Years
Min: 0.78  Med: 2.65 Max: 54.57
Current: 15.42
0.78
54.57
Earnings Yield (Greenblatt) (%) 3.03
COO's Earnings Yield (Greenblatt) (%) is ranked higher than
56% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. COO: 3.03 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
COO' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.4  Med: 4.7 Max: 8.8
Current: 3.03
1.4
8.8
Forward Rate of Return (Yacktman) (%) 9.35
COO's Forward Rate of Return (Yacktman) (%) is ranked higher than
53% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. COO: 9.35 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
COO' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2  Med: 14.6 Max: 23.1
Current: 9.35
-2
23.1

More Statistics

Revenue (TTM) (Mil) $1,904
EPS (TTM) $ 5.11
Beta0.61
Short Percentage of Float5.75%
52-Week Range $119.28 - 190.99
Shares Outstanding (Mil)48.74

Analyst Estimate

Oct16 Oct17
Revenue (Mil $) 1,955 2,106
EPS ($) 8.29 9.57
EPS w/o NRI ($) 8.29 9.57
EPS Growth Rate
(3Y to 5Y Estimate)
10.49%
Dividends Per Share ($) 0.06 0.07
» More Articles for COO

Headlines

Articles On GuruFocus.com
Weekly CEO Sells Highlights Jul 06 2016 
Weekly CFO Sells Highlight Jun 13 2016 
Baron Funds Comments on The Cooper Companies Jan 26 2016 
Steve Mandel Buys Visa, DaVita Healthcare In Q4 Feb 19 2015 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Weekly CEO Sells Highlight: Cooper Companies, Broadcom Corp, Realpage Inc, and Freescale Semiconduct Jul 14 2014 
Baron Funds Comments on The Cooper Companies May 02 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Manning & Napier New Buys of Q1 Apr 19 2013 
The Cooper Companies: Not Eyeing It Yet Nov 27 2012 

More From Other Websites
How The Cooper Companies Inc (COO) Stacks Up Against Its Peers Dec 01 2016
6 stocks to watch Dec 01 2016
Research Reports Initiation on Medical Supplies Stocks -- Cooper Cos., Glaukos, Insulet, and CR Bard Nov 15 2016
The Cooper Cos., Inc. breached its 50 day moving average in a Bullish Manner : COO-US : November 9,... Nov 09 2016
COOPER COMPANIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 07 2016
The Cooper Companies Acquires Wallace From Smiths Medical Nov 07 2016
The Cooper Companies Acquires Wallace From Smiths Medical Nov 07 2016
11 improving health-care companies whose stocks are loved by analysts Nov 04 2016
The Cooper Companies Announces Release Date for Fourth Quarter and Full Year 2016 Nov 03 2016
The Cooper Companies Announces Release Date for Fourth Quarter and Full Year 2016 Nov 03 2016
What's in Store for GNC Holdings (GNC) in Q3 Earnings? Oct 24 2016
Sectornomics: Health care winners and laggards Oct 21 2016
Reprogenetics, Recombine, and Genesis Genetics Unite As Part of the CooperSurgical Family at ASRM... Oct 17 2016
St. Jude (STJ) Launches PressureWire X After FDA Clearance Oct 14 2016
LabCorp (LH): Inorganic Growth, Innovation Continues Oct 13 2016
Align Technology's Invisalign G7 Launch Targets Teen Market Oct 12 2016
The Cooper Cos., Inc. : COO-US: Dividend Analysis : July 22nd, 2016 (record date) : By the numbers :... Oct 06 2016
ETF’s with exposure to The Cooper Cos., Inc. : September 30, 2016 Sep 30 2016
The Cooper Cos., Inc. breached its 50 day moving average in a Bearish Manner : COO-US : September... Sep 26 2016
The Cooper Companies (COO) Set to Join the S&P 500 Index Sep 21 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)